Analyst Hartaj Singh works at OPPENHEIMER and is focused on the Healthcare sector with 181 price targets and ratings documented since 2015 spanning on 19 stocks. Previously, Hartaj Singh worked at BTIG. Analyst's average stock valuation to be materialised ratio is 56.88% with an average time for price targets to be met of 319.54 days.
Most recent stock forecast was given on GILD, Gilead Sciences, Inc at 01-Dec-2022.
Hartaj Singh best performing recommendations are on SNSS.
The best stock recommendation documented was for MRNA (MODERNA, INC) at 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%) receiving and performance score of 77.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
205
$22.5 (12.33%)
1 years 9 months 1 days ago
4/6 (66.67%)
$35.77 (24.78%)
715
Hold
173
$-9.5 (-5.21%)
156
1 years 9 months 3 days ago
15/27 (55.56%)
$53.78 (43.26%)
659
Hold
190
$7.5 (4.11%)
190
1 years 9 months 11 days ago
12/15 (80%)
$25.6 (21.95%)
474
Buy
166
$-16.5 (-9.04%)
175
2 years 2 days ago
23/24 (95.83%)
$57.5 (50.98%)
786
Hold
155
2 years 29 days ago
11/11 (100%)
$47.59 (43.76%)
415
